Vera Jankowski - Concepedia

Author

Vera Jankowski

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Jankowski, Vera, Joachim Jankowski, McPherson, M., Thomas Clavel, V Jankowski, V. Jankowski, Vera Jankowski

259

Publications

5.8K

Citations

H-Index

140

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin RWTH Aachen University Maastricht University Mosaiques Diagnostics and Therapeutics (Germany)Universitätsklinikum Aachen

About

Vera Jankowski is an author at Charité - Universitätsmedizin Berlin specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	41	1.8K
2	Biochemistry	10	10	309
3	Engineering	7	7	211
4	Natural Sciences	6	6	231
5	Health Sciences	2	2	58

Vera Jankowski

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Discovery and Characterization of Alamandine Roberto Queiroga Lautner, Daniel Campos Villela, Rodrigo A. Fraga-Silva, Circulation Research	2013	424
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation Stephen Zewinger, Jochen Reiser, Vera Jankowski, Nature Immunology InflammationAnti-inflammatoryAutoimmune DiseaseMedicineImmunology	2019	262
Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma Vera Jankowski, Raymond Vanholder, Markus van der Giet, Arteriosclerosis Thrombosis and Vascular Biology	2006	190
Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor Vera Jankowski, Markus Tölle, Raymond Vanholder, Nature Medicine Signal TransductionUridine Adenosine TetraphosphateMedicinePhysiologyEndothelial Dysfunction	2005	151
Carbamylated low-density lipoprotein induces endothelial dysfunction Thimoteus Speer, Frederick O. Owala, Erik W. Holy, European Heart Journal	2014	151
High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A Markus Tölle, Tao Huang, Mirjam Schuchardt, Cardiovascular Research	2012	136
Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P <sub>3</sub> Markus Tölle, Bodo Levkau, Petra Keul, Circulation Research Vascular DiseaseImmunologyImmunomodulator Fty720InflammationAngiogenesis	2005	122
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression Joachim Jankowski, Markus van der Giet, Vera Jankowski, Journal of Clinical Investigation	2003	115
Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis Agnieszka Latosińska, Konstantinos Vougas, Manousos Makridakis, PLoS ONE PathologyItraq-labeled PeptidesProteomic TechnologyBioanalysisBiostatistics	2015	104
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression Joachim Jankowski, Markus van der Giet, Vera Jankowski, Journal of Clinical Investigation	2003	98

Page 1